vs

Side-by-side financial comparison of CRYO CELL INTERNATIONAL INC (CCEL) and Direct Digital Holdings, Inc. (DRCT). Click either name above to swap in a different company.

Direct Digital Holdings, Inc. is the larger business by last-quarter revenue ($8.4M vs $7.8M, roughly 1.1× CRYO CELL INTERNATIONAL INC). CRYO CELL INTERNATIONAL INC runs the higher net margin — -48.7% vs -138.7%, a 90.0% gap on every dollar of revenue. On growth, CRYO CELL INTERNATIONAL INC posted the faster year-over-year revenue change (-2.3% vs -7.4%). Over the past eight quarters, CRYO CELL INTERNATIONAL INC's revenue compounded faster (-0.1% CAGR vs -38.6%).

Cryo-Cell International, Inc. is a cord blood bank. It was founded by Dan Richard in 1989. Cryo-Cell International is the first private cord blood bank to separate and store stem cells. Cryo-Cell is headquartered outside of Tampa, in Oldsmar, Florida. In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol CCEL.

Devolver Digital, Inc. is an American video game publisher based in Austin, Texas, specializing in the publishing of indie games. The company was founded in June 2009 by Nigel Lowrie, Harry Miller, Graeme Struthers, Rick Stults, and Mike Wilson, five executives who had been involved with Gathering of Developers and Gamecock Media Group, which published games on developer-friendly terms, but due to the high cost associated with releasing retail games saw themselves acquired and dissolved by la...

CCEL vs DRCT — Head-to-Head

Bigger by revenue
DRCT
DRCT
1.1× larger
DRCT
$8.4M
$7.8M
CCEL
Growing faster (revenue YoY)
CCEL
CCEL
+5.2% gap
CCEL
-2.3%
-7.4%
DRCT
Higher net margin
CCEL
CCEL
90.0% more per $
CCEL
-48.7%
-138.7%
DRCT
Faster 2-yr revenue CAGR
CCEL
CCEL
Annualised
CCEL
-0.1%
-38.6%
DRCT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CCEL
CCEL
DRCT
DRCT
Revenue
$7.8M
$8.4M
Net Profit
$-3.8M
$-11.7M
Gross Margin
77.9%
26.8%
Operating Margin
-50.6%
-53.4%
Net Margin
-48.7%
-138.7%
Revenue YoY
-2.3%
-7.4%
Net Profit YoY
-105.1%
-434.7%
EPS (diluted)
$-0.46
$-74.97

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CCEL
CCEL
DRCT
DRCT
Q4 25
$7.8M
$8.4M
Q3 25
$7.8M
$8.0M
Q2 25
$7.9M
$10.1M
Q1 25
$8.0M
$8.2M
Q4 24
$8.0M
$9.1M
Q3 24
$8.1M
$9.1M
Q2 24
$8.0M
$21.9M
Q1 24
$7.9M
$22.3M
Net Profit
CCEL
CCEL
DRCT
DRCT
Q4 25
$-3.8M
$-11.7M
Q3 25
$749.4K
$-2.7M
Q2 25
$355.8K
$-2.2M
Q1 25
$282.9K
$-2.4M
Q4 24
$-1.9M
$-2.2M
Q3 24
$1.1M
$-2.7M
Q2 24
$655.8K
$-590.0K
Q1 24
$556.2K
$-775.0K
Gross Margin
CCEL
CCEL
DRCT
DRCT
Q4 25
77.9%
26.8%
Q3 25
77.0%
27.7%
Q2 25
76.6%
35.1%
Q1 25
75.1%
29.3%
Q4 24
78.4%
32.5%
Q3 24
73.6%
38.7%
Q2 24
74.8%
27.1%
Q1 24
73.7%
22.4%
Operating Margin
CCEL
CCEL
DRCT
DRCT
Q4 25
-50.6%
-53.4%
Q3 25
24.3%
-49.0%
Q2 25
18.8%
-23.9%
Q1 25
13.3%
-48.1%
Q4 24
-1.5%
-51.8%
Q3 24
17.2%
-40.3%
Q2 24
17.3%
-9.4%
Q1 24
10.5%
-12.6%
Net Margin
CCEL
CCEL
DRCT
DRCT
Q4 25
-48.7%
-138.7%
Q3 25
9.6%
-33.6%
Q2 25
4.5%
-22.2%
Q1 25
3.5%
-28.9%
Q4 24
-23.2%
-24.0%
Q3 24
13.0%
-29.6%
Q2 24
8.2%
-2.7%
Q1 24
7.1%
-3.5%
EPS (diluted)
CCEL
CCEL
DRCT
DRCT
Q4 25
$-0.46
$-74.97
Q3 25
$0.09
$-0.24
Q2 25
$0.04
$-0.23
Q1 25
$0.03
$-0.35
Q4 24
$-0.23
$-90.17
Q3 24
$0.13
$-0.71
Q2 24
$0.08
$-0.16
Q1 24
$0.07
$-0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CCEL
CCEL
DRCT
DRCT
Cash + ST InvestmentsLiquidity on hand
$3.3M
$728.0K
Total DebtLower is stronger
$8.4M
Stockholders' EquityBook value
$-18.6M
$-7.0M
Total Assets
$61.7M
$20.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CCEL
CCEL
DRCT
DRCT
Q4 25
$3.3M
$728.0K
Q3 25
$3.2M
$871.0K
Q2 25
$4.4M
$1.6M
Q1 25
$3.5M
$1.8M
Q4 24
$3.5M
$1.4M
Q3 24
$2.1M
$4.1M
Q2 24
$1.5M
$1.1M
Q1 24
$979.6K
$3.3M
Total Debt
CCEL
CCEL
DRCT
DRCT
Q4 25
$8.4M
Q3 25
$8.4M
$10.8M
Q2 25
$8.4M
$33.5M
Q1 25
$8.5M
$32.9M
Q4 24
$8.5M
Q3 24
$8.5M
$150.0K
Q2 24
$8.5M
$34.8M
Q1 24
$8.6M
$32.4M
Stockholders' Equity
CCEL
CCEL
DRCT
DRCT
Q4 25
$-18.6M
$-7.0M
Q3 25
$-14.8M
$-6.7M
Q2 25
$-15.6M
$-24.6M
Q1 25
$-14.7M
$-23.3M
Q4 24
$-13.2M
$-19.7M
Q3 24
$-9.6M
$-16.7M
Q2 24
$-10.7M
$-10.5M
Q1 24
$-10.3M
$-7.5M
Total Assets
CCEL
CCEL
DRCT
DRCT
Q4 25
$61.7M
$20.2M
Q3 25
$63.2M
$22.5M
Q2 25
$64.4M
$23.3M
Q1 25
$64.4M
$23.8M
Q4 24
$64.7M
$26.0M
Q3 24
$62.9M
$31.3M
Q2 24
$62.6M
$48.5M
Q1 24
$61.7M
$52.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CCEL
CCEL
DRCT
DRCT
Operating Cash FlowLast quarter
$1.3M
$-1.9M
Free Cash FlowOCF − Capex
$1.2M
FCF MarginFCF / Revenue
15.5%
Capex IntensityCapex / Revenue
0.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$5.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CCEL
CCEL
DRCT
DRCT
Q4 25
$1.3M
$-1.9M
Q3 25
$2.5M
$-1.6M
Q2 25
$707.0K
$-2.7M
Q1 25
$954.1K
$-2.7M
Q4 24
$2.2M
$-1.6M
Q3 24
$2.4M
$3.0M
Q2 24
$1.8M
$-4.4M
Q1 24
$-356.9K
$-5.7M
Free Cash Flow
CCEL
CCEL
DRCT
DRCT
Q4 25
$1.2M
Q3 25
$2.5M
Q2 25
$644.6K
Q1 25
$892.0K
Q4 24
$2.1M
Q3 24
$2.3M
Q2 24
$21.5K
Q1 24
$-814.6K
FCF Margin
CCEL
CCEL
DRCT
DRCT
Q4 25
15.5%
Q3 25
31.9%
Q2 25
8.1%
Q1 25
11.2%
Q4 24
26.8%
Q3 24
27.9%
Q2 24
0.3%
Q1 24
-10.4%
Capex Intensity
CCEL
CCEL
DRCT
DRCT
Q4 25
0.9%
Q3 25
0.5%
Q2 25
0.8%
Q1 25
0.8%
Q4 24
0.1%
Q3 24
2.3%
Q2 24
21.8%
Q1 24
5.8%
Cash Conversion
CCEL
CCEL
DRCT
DRCT
Q4 25
Q3 25
3.38×
Q2 25
1.99×
Q1 25
3.37×
Q4 24
Q3 24
2.32×
Q2 24
2.70×
Q1 24
-0.64×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CCEL
CCEL

Segment breakdown not available.

DRCT
DRCT

Buy Side Advertising$8.2M98%
Other$183.0K2%

Related Comparisons